Literature DB >> 30908318

Spectrum and Yield to Dose Conversion Coefficients for Beta Skin Doses Linked to the Q System.

Thomas Frosio1, Philippe Bertreix1, Ulli Köster2, Christian Theis1, Matteo Magistris1.   

Abstract

Monte Carlo simulations are a state-of-the-art method to calculate dose coefficients and could be used with the Q system for radioactive material packaging. These simulations often take a long time to converge with sufficient precision. Furthermore, if multiple sources have to be taken into account, many weeks of calculations may be needed. In order to reduce the calculation time, this paper proposes a new method based on a transfer function to instantly compute Q values associated with beta skin doses. The method developed in this paper can be applied to compute beta skin dose and easily could be extended to other particles and different depths in organs with various kinds of shielding configurations between source and target.

Mesh:

Year:  2019        PMID: 30908318      PMCID: PMC6571186          DOI: 10.1097/HP.0000000000000986

Source DB:  PubMed          Journal:  Health Phys        ISSN: 0017-9078            Impact factor:   1.316


  3 in total

1.  Personal dose equivalent conversion coefficients for electrons to 1 Ge V.

Authors:  K G Veinot; N E Hertel
Journal:  Radiat Prot Dosimetry       Date:  2011-06-29       Impact factor: 0.972

2.  CALCULATION OF SKIN DOSE DUE TO BETA CONTAMINATION USING THE NEW QUANTITY OF THE ICRP 116: THE 'LOCAL SKIN DOSE'.

Authors:  L Bourgois; S Ménard; N Comte
Journal:  Radiat Prot Dosimetry       Date:  2017-11-01       Impact factor: 0.972

3.  COMPILATION OF CONVERSION COEFFICIENTS FOR THE DOSE TO THE LENS OF THE EYE.

Authors:  R Behrens
Journal:  Radiat Prot Dosimetry       Date:  2017-04-28       Impact factor: 0.972

  3 in total
  1 in total

1.  How Efficient Are Monte Carlo Calculations Together With the Q-System to Determine Radioactive Transport Limits? Case Study on Medical Radionuclides.

Authors:  Maddalena Maietta; Ferid Haddad; Sebastien Avila
Journal:  Front Med (Lausanne)       Date:  2022-07-13
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.